Study Title: Randomized Phase II/III Trial of Radiation with High Dose Cisplatin (100mg/m2) Every Three Weeks Versus Radiation with Low Dose Cisplatin (40mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
For more information about the trial above please contact the study team:Self Regional Medical CenterAffiliate Principal Investigator, Wood, Clint, at clint.wood@selfregional.org.Study Coordinator, Blalock, Margaret, at margaret.bentley@selfregional.org.Trial opened at the following institutions: Self Regional Medical Center